DIVIS LABORATORIES LIMITED FACTORY

DIVIS LABORATORIES LIMITED FACTORY Company Introduction

Divi's Laboratories Limited is a leading Indian pharmaceutical company primarily engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs), intermediates, and nutraceutical ingredients. Established in 1990, the company has grown to become one of the world's largest manufacturers of generic APIs and a significant provider of custom synthesis services for global pharmaceutical companies.

The company is widely recognized for its strong research and development capabilities, adherence to stringent quality control standards, and large-scale, cost-effective manufacturing operations. Divi's operates multiple state-of-the-art manufacturing facilities that are approved by major international regulatory bodies, including the US FDA, EU GMP, and various other health authorities. Its extensive product portfolio covers a wide range of therapeutic areas, and the company is particularly noted for its expertise in complex chemistry and advanced manufacturing processes.

Divi's Laboratories Limited is a factory. It is a manufacturer.

Divis Laboratories Limited produces or sells the following products:

Naproxen

Dextromethorphan

Gabapentin

Levetiracetam

Pregabalin

Valsartan

Telmisartan

Olmesartan

Sacubitril

Carbidopa

Levodopa

Furosemide

Atorvastatin

Rosuvastatin

Simvastatin

Candesartan

Irbesartan

Losartan

Ezetimibe

Omeprazole

Pantoprazole

Lansoprazole

Esomeprazole

Ursodeoxycholic acid (UDCA)

Lutein

Zeaxanthin

Beta-carotene

Omega-3 Fatty Acids (EPA and DHA)

Chondroitin Sulfate

Glucosamine Sulfate